BNP PARIBAS FINANCIAL MARKETS - ANIKA THERAPEUTICS INC ownership

ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 167 filers reported holding ANIKA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of ANIKA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$264,006
+2.2%
14,171
+42.5%
0.00%
Q2 2023$258,423
-46.7%
9,947
-41.1%
0.00%
-100.0%
Q1 2023$484,650
+72.4%
16,875
+77.7%
0.00%
Q4 2022$281,082
-99.9%
9,496
-47.1%
0.00%
-100.0%
Q3 2022$427,281,000
+283.5%
17,953
+259.6%
0.00%
Q2 2022$111,421,000
-16.1%
4,992
-5.6%
0.00%
Q1 2022$132,782,000
-60.9%
5,288
-44.1%
0.00%
Q4 2021$339,238,000
-47.5%
9,468
-37.6%
0.00%
-100.0%
Q3 2021$645,763,000
+127.5%
15,173
+131.4%
0.00%
Q2 2021$283,853,000
-13.2%
6,557
-18.2%
0.00%
Q1 2021$327,095,000
+183.2%
8,019
+214.2%
0.00%
Q4 2020$115,504,000
-7.4%
2,552
-27.6%
0.00%
Q3 2020$124,679,000
-80.8%
3,523
-79.5%
0.00%
-100.0%
Q2 2020$649,409,000
-30.3%
17,212
-46.6%
0.00%
-50.0%
Q1 2020$932,145,000
+414.2%
32,243
+822.3%
0.00%
Q4 2019$181,268,000
+31.8%
3,496
+39.5%
0.00%
Q3 2019$137,554,000
+119.6%
2,506
+62.5%
0.00%
Q2 2019$62,636,000
-28.4%
1,542
-46.7%
0.00%
Q1 2019$87,424,000
+310.3%
2,891
+356.0%
0.00%
Q4 2018$21,309,000
+1.2%
634
+27.1%
0.00%
Q3 2018$21,048,000
-61.9%
499
-71.1%
0.00%
Q2 2018$55,232,000
-76.5%
1,726
-63.5%
0.00%
Q1 2018$235,126,000
-69.1%
4,729
-66.4%
0.00%
-100.0%
Q4 2017$759,754,000
+80.1%
14,093
+93.8%
0.00%0.0%
Q3 2017$421,834,000
+98.1%
7,273
+68.6%
0.00%0.0%
Q2 2017$212,902,000
+17.0%
4,315
+3.0%
0.00%
Q1 2017$181,970,000
-17.2%
4,189
-6.7%
0.00%
-100.0%
Q4 2016$219,879,000
+103.0%
4,491
+98.4%
0.00%
Q3 2016$108,332,000
-56.9%
2,264
-51.7%
0.00%
-100.0%
Q2 2016$251,350,000
+124.7%
4,685
+87.3%
0.00%
Q1 2016$111,845,000
+3.3%
2,501
-11.9%
0.00%
Q4 2015$108,298,000
+7.3%
2,838
-10.5%
0.00%
Q3 2015$100,901,000
+151.0%
3,170
+160.5%
0.00%
Q2 2015$40,198,000
+178.2%
1,217
+246.7%
0.00%
Q1 2015$14,451,000
-63.2%
351
-67.2%
0.00%
Q3 2014$39,226,000
+1528.3%
1,070
+1957.7%
0.00%
Q2 2014$2,409,000
+31.1%
52
+20.9%
0.00%
Q1 2014$1,838,000
-73.1%
43
-76.0%
0.00%
Q4 2013$6,831,0001790.00%
Other shareholders
ANIKA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Trigran Investments, Inc. 1,154,183$25,761,0003.00%
CAPITAL MANAGEMENT CORP /VA 275,130$6,141,0001.52%
Kent Lake Capital LLC 98,570$2,200,0001.21%
DIKER MANAGEMENT LLC 21,835$487,0000.60%
Portolan Capital Management 235,972$5,267,0000.53%
Riverwater Partners LLC 12,466$278,0000.28%
Ranger Investment Management 139,661$3,117,0000.24%
Invenomic Capital Management LP 144,287$3,220,0000.23%
CHATHAM CAPITAL GROUP, INC. 23,787$531,0000.12%
Teton Advisors, Inc. 22,000$491,0000.10%
View complete list of ANIKA THERAPEUTICS INC shareholders